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Background: It is increasingly recognized that standing represents a simple solution to extended periods of sitting.
However, it is currently unknown whether workplace standing time is prospectively associated with a lower
incidence of chronic diseases. The objective of this study was to examine the association between workplace
standing time and the incidence of overweight/obesity (OW/OB) and impaired glucose tolerance/type 2 diabetes
(IGT/T2D) in adults.
Methods: A longitudinal analysis from the Quebec Family Study (Canada) was conducted on 293 participants, aged
18 to 65 years, followed for a mean of 6 years. Information on self-reported occupational standing time as well as
several covariates was collected at both baseline and follow-up. Outcome measures included the development of
OW/OB (i.e. body mass index ≥25 kg/m2) and IGT/T2D (i.e. 2-h postload plasma glucose level ≥7.8 mmol/L).
Results: The incidence rates of OW/OB and IGT/T2D over the 6-year follow-up period were 17.4% and 12.6%,
respectively. Significant negative associations were observed between the amount of occupational standing time
and the development of outcome measures. However, the associations were no longer significant after adjustment
for age, sex, smoking habits, total annual family income, daily caloric intake, and submaximal working capacity.
In age- and sex-adjusted logistic regression analysis, significant negative linear trends were observed across levels
of standing time and the outcome variables. However, the associations were no longer significant after further
adjustment for the other covariates. Finally, we observed that the change in standing time from baseline to year 6
was significantly associated with the development of outcome measures, with higher incidence rates in adults
reporting a reduction in standing time at follow-up. However, the associations became non-significant after
adjustment for covariates.
Conclusions: Greater occupational standing time is not sufficient in and of itself to prevent the development of
OW/OB and IGT/T2D in adults. Future efforts are needed to better understand the potential benefits of higher
amounts of standing time throughout the day on the prevention of chronic diseases.
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Accumulating evidence associates sedentary behavior (e.g.
sitting) with adverse health outcomes including obesity
and type 2 diabetes [1-5]. Studies also suggest that the ef-
fects of sedentary behavior on health indicators may be in-
dependent of moderate-to-vigorous physical activity [6-8].
However, many low-energy-expenditure activities can be
classified as “sedentary behaviors” (e.g. reading, television
viewing, driving) with effects that may be different on
health indicators depending on the specific behavior
[9-12]. Among behaviors at the low end of the energy ex-
penditure continuum, standing has not received much at-
tention in its ability to prevent the development of adverse
health outcomes.
Breaking up sedentary time has recently been shown
to be promising for improving cardiometabolic health
[13-18]. One of the easiest ways to interrupt prolonged
sitting is to stand up. Although standing quietly involves
low levels of energy expenditure (approximately 1.2
METs), it engages a large muscle mass in the lower ex-
tremities and may represent a healthier alternative to sit-
ting. Interestingly, a recent study reported that greater
time spent standing was associated with a lower risk of
mortality in adults [19]. Small-scale intervention studies
also suggest that replacing workplace sitting with standing
may reduce the glycemic response to a test meal [20,21].
However, it is unknown whether workplace standing
time is prospectively related to a lower incidence of
chronic diseases. Given that standing represents a sim-
ple solution to reduce extended periods of sitting, it is
of interest to understand the association between stand-
ing and cardiometabolic health.
Therefore, the objective of this study was to examine
the association between occupational standing time and
the incidence of overweight/obesity (OW/OB) and im-
paired glucose tolerance/type 2 diabetes (IGT/T2D) in
adults. We hypothesized that greater amounts of stand-




The Quebec Family Study was initiated at Laval University
in 1978. The primary objective of this study was to investi-
gate the genetics of fitness, body composition and cardio-
vascular risk factors. In phase 1 of the study (1979 to
1982), a total of 1650 individuals from 375 families (nu-
clear families with biological or adopted offspring, pairs of
twins of both types, and uncle/aunt and nephew and niece
when available) were recruited and assessed. Recruitment
was conducted irrespective of body weight during phase 1,
resulting in a cohort with a wide range of body mass index
levels. In phase 2 (1989–1997) and 3 (1998–2002), 100
families from phase 1 were retested, and an additional 123families with at least 1 parent and 1 offspring with a body
mass index of 32 kg/m2 or higher were added to the co-
hort. Families were all of French descent and were living
for the most part within 80 km of Quebec City (Canada).
Details on recruitment procedures and other aspects of
the Quebec Family Study can be found elsewhere [22,23].
This cohort thus represents a mixture of random sampling
and ascertainment through obese individuals. The present
analyses are based on participants tested in phases 2
and 3 because some measurements were not available
in phase 1. Adults between 18 and 65 years of age were
selected for longitudinal analyses (n = 293). A total of 23
participants were excluded because they were outside
this age range. The mean duration of follow-up between
phase 2 and 3 was 6.0 ± 0.9 years. All subjects provided
written informed consent to participate in the study.
The project was approved by the Medical Ethics Com-
mittee of Laval University.
Standing time assessment
To assess the primary exposure variable, participants
completed a questionnaire and answered the following
question: “How much time do you spend standing dur-
ing your main occupation (e.g. at work)?” Responses in-
cluded (i) all the time, (ii) most of the time, (iii) half of
the time, and (iv) rarely/never. The assessment was per-
formed at both baseline and after 6 years.
Assessment of outcome variables
Overweight/obesity (OW/OB)
At both baseline and year 6, height was measured to the
nearest 0.1 cm using a stadiometer, and body weight was
measured to the nearest 0.1 kg using a digital panel indi-
cator scale (Beckman Industrial Ltd, Model 610/612,
Scotland, UK). Body mass index (BMI) was calculated as
body weight divided by height squared (kg/m2). OW/OB
was defined as a BMI ≥25 kg/m2, in agreement with
well-established international standards [24]. OW/OB
were combined in the analyses due to the low incidence
of OB alone.
Impaired glucose tolerance/type 2 diabetes (IGT/T2D)
A 75 g oral glucose tolerance test was performed in the
morning after a 12-h overnight fast. Blood samples were
collected in tubes containing EDTA and Trasylol (Miles
Pharmaceutics, Rexdale, ON, Canada) through a venous
catheter from an antecubital vein at −15, 0, 15, 30,
45, 60, 90, 120, 150 and 180 min. Plasma glucose con-
centration was measured enzymatically [25], and fasting
glucose concentration was calculated as the mean of
the −15 and 0 min concentrations. T2D and IGT were
defined according to the American Diabetes Association
and the World Health Organization criteria [26,27]. T2D
was defined as use of insulin or a hypoglycemic agent, a
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(≥7.0 mmol/L), or a 2-h postload plasma glucose level of
200 mg/dL or more (≥11.1 mmol/L). On the other hand,
IGT was defined as a 2-h postload plasma glucose level
of 140 mg/dL or more (≥7.8 mmol/L) in participants not
meeting the criteria for T2D. The measurements were
performed the same way at both baseline and follow-up.
Similar to OW/OB, we combined IGT and T2D cases.
Covariates
Numerous variables were measured via self-reported
questionnaires at baseline and year 6. These included
age, sex, smoking habits (smoker or nonsmoker), and
total annual family income (Canadian dollars per year).
Additionally, daily energy intake (kcal/day) was assessed
with a 3-day food record (two week days and one week-
end day). This method of dietary assessment has been
shown to provide a reasonably reliable measurement of
food intake in this population [28]. Finally, physical work
capacity at a heart rate of 150 bpm (PWC150), deter-
mined by a progressive exercise test on a modified
Monark cycle ergometer, was used as an indicator of
cardiorespiratory fitness, as previously described [29].
PWC150 is expressed in kilopond per minute per kilo-
gram (kpm/kg) to take individual differences in body
weight into account. These 6 covariates were chosen be-
cause of their association with the exposure and out-
comes and on the basis of previous research [1,2,17,19].
Given that over-fitting can be a concern with our relatively
small sample size, different analyses were conducted to as-
sess model fit (including testing for multicollinearity) and
results demonstrated that our models had good predictive
performance and were not subject to over-fitting.
Statistical analysis
To determine if men and women could be combined,
sex-by-standing time interactions were assessed for all
dependent variables. No significant interactions were
found, therefore data for both sexes were combined to
maximize power. Baseline characteristics of participants
by standing time category were compared by analysis
of variance (continuous variables) or chi-squared test
(categorical variables). Among participants free of the
outcome of interest at baseline (n = 151 normal weight
and n = 260 without IGT/T2D), the incidence of OW/
OB and IGT/T2D by standing time category over the 6-
year follow-up period was calculated and a chi-squared
test was used to assess statistical significance. Multivari-
able logistic regression analysis was also used to evaluate
the risk for the development of OW/OB and IGT/T2D
according to the amount of standing time. The category
“rarely/never” was used as the reference group. The re-
sults from two models are presented: (i) adjusted for age
and sex and (ii) additionally adjusted for smoking habits,total annual family income, daily caloric intake, and
submaximal working capacity. Odds ratios (OR) and
95% confidence intervals (CI) were reported. Finally, a
chi-squared test was used to compare the incidence of
OW/OB and IGT/T2D across categories of changes in
standing time between baseline and year 6 (decreased,
maintained, increased). Because some individuals in
this study came from the same nuclear family and are
biologically related, we adjusted for clustering in the
analyses using the generalized estimating equations stat-
istical method to avoid underestimation of standard de-
viations. This procedure allowed us to model standing
time and covariates as repeated measures at two time
points (baseline and 6 years later), thus taking into
account both measures over time. A 2-tailed P value of
less than 0.05 was the threshold to indicate statistical
significance. All statistical analyses were performed using
JMP version 11 (SAS Institute, Cary, NC).
Results
Baseline characteristics of participants within each
standing time group are shown in Table 1. Among the
293 Caucasian participants of this study, 33% reported
standing rarely or never, 23% half of the time, 19% most
of the time, and 25% all the time during their main
occupation.
Over the 6-year follow-up period, 51 new cases of
OW/OB (17.4%) and 37 new cases of IGT/T2D (12.6%)
were observed (there were 151 normal weight partici-
pants and 260 without IGT/T2D at baseline). As shown
in Figure 1, a negative dose–response association was
observed between the amount of standing time and the
development of OW/OB and IGT/T2D (P < 0.05). How-
ever, the associations were no longer significant after
adjusting for covariates (age, sex, smoking habits, total
annual family income, daily caloric intake, and submaxi-
mal working capacity) (data not shown). Specifically,
total annual family income and submaximal working
capacity were the main confounders of the relationship
(data not shown).
The results of the multivariable logistic regression ana-
lysis assessing the relationship between standing time
and the development of OW/OB and IGT/T2D are pre-
sented in Table 2. In the age- and sex-adjusted analyses,
there were significant negative linear trends across levels
of standing time and the outcome variables. However,
the associations were no longer significant after further
adjustment for smoking habits, total annual family in-
come, daily caloric intake and submaximal working
capacity. Here again, the addition of total annual family
income and submaximal working capacity to the models
resulted to the greater attenuation of ORs (data not
shown). Of note, the delta ORs between the “Rarely/
Never” standing group and the “All the time” standing
Table 1 Baseline descriptive characteristics of participants across levels of standing time
Rarely/Never Half of the time Most of the time All the time P
(n = 97) (n = 66) (n = 57) (n = 73)
Age (years) 37.3 ± 14.7 42.2 ± 13.7 42.6 ± 14.0 35.6 ± 12.2 <0.01
Sex
Men (%) 56 37 37 43
Women (%) 44 63 63 57 0.04
Body mass index (kg/m2) 25.7 ± 5.5 26.3 ± 6.3 25.1 ± 4.5 25.2 ± 5.6 0.61
Waist circumference (cm) 85.0 ± 14.9 84.4 ± 16.8 82.2 ± 12.6 81.9 ± 15.6 0.53
Weight statusa
Normal weight (%) 50 52 58 59
Overweight (%) 35 22 29 26
Obese (%) 15 26 13 15 0.35
Diabetes statusb
Normal (%) 84 76 81 95
IGT (%) 10 20 14 3
Type 2 diabetes (%) 6 4 5 2 0.08
Smoking habits
Nonsmoker (%) 84 87 85 79
Smoker (%) 16 13 15 21 0.64
Total annual family income ($C) 66,848 ± 26,846 54,180 ± 24,886 52,700 ± 21,740 56,323 ± 23,238 <0.01
Energy intake (kcal/day) 2,329 ± 634 2,211 ± 648 2,226 ± 647 2,498 ± 979 0.11
PWC150 (kpm/kg) 9.3 ± 2.9 8.9 ± 2.4 8.5 ± 3.6 9.1 ± 3.2 0.68
Values are presented as mean ± SD for continuous variables and percentage (%) for categorical variables. Statistical significance was assessed by analysis of
variance with continuous variables and by a chi-squared test with categorical variables. aNormal weight (body mass index between 18.5 and 24.9 kg/m2),
overweight (body mass index between 25.0 and 29.9 kg/m2) and obese (body mass index ≥30 kg/m2). bType 2 diabetes and impaired glucose tolerance were
defined according to the American Diabetes Association and the World Health Organization criteria [26,27]. Abbreviations: IGT impaired glucose tolerance; PWC150
physical work capacity at a heart rate of 150 bpm.
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0.63) to 12% (0.97 to 0.85) and from a difference of 27%
(0.91 to 0.66) to 5% (0.96 to 0.91) for OW/OB and IGT/
T2D, respectively, after multivariable adjustment.
Finally, the incidence of OW/OB and IGT/T2D across
categories of changes in standing time is shown in
Figure 2. We observed that the change in standing time
(from baseline to year 6) was significantly associated
with the development of OW/OB and IGT/T2D, with
higher incidence rates in adults reporting a reduction in
standing time at follow-up. However, the associations
became non-significant after adjustment for covariates,
especially total annual family income and submaximal
working capacity (data not shown).
Discussion
Overall, we observed that greater amounts of occupa-
tional standing time are associated with a lower inci-
dence of OW/OB and IGT/T2D in this sample of adults.
However, greater time spent standing was not sufficient
in and of itself to prevent the development of outcome
measures. The addition of confounding factors to the
models, especially annual income and cardiorespiratoryfitness, led to non-significant associations. Thus, our re-
sults suggest that workplace standing time alone is not
sufficient to prevent the incidence of OW/OB and IGT/
T2D. Future efforts are needed to better understand the
added value of standing time for overall health.
Sitting has become pervasive in today’s environment
[30-32] and studies have provided compelling evidence
that excessive sitting is associated with the development
of several chronic diseases and premature mortality
[2,5,19]. Recent intervention studies suggest that re-
placing sitting with standing may result in rapid and
positive changes in important health markers [20,21,33].
For example, Buckley et al. compared the impact of an
afternoon of seated vs. standing office work in a group
of 10 adults [20]. In comparison to the seated condition,
they reported that participants burned 174 kcal more
during the standing condition, and also demonstrated a
43% lower glycemic response following a test meal. Simi-
larly, Thorp et al. reported that alternating between sit-
ting and standing every 30 minutes resulted in an 11%
lower glycemic response to a test meal, when compared
to a typical (e.g. sitting) workstation [21]. These inter-
vention studies are supported by the recent paper of
Figure 1 Development of overweight/obesity (A) and impaired
glucose tolerance/type 2 diabetes (IGT/T2D) (B) according to
categories of standing time over the 6-year follow-up period
in adults. Data are presented as percentage. Overweight/obesity
was defined as a body mass index ≥25 kg/m2. Impaired glucose
tolerance/type 2 diabetes was defined according to the American
Diabetes Association and the World Health Organization criteria
[26,27]. Statistical significance was assessed by a chi-squared test
(P < 0.05 for all analyses). Standing categories: rarely/never (n = 97),
half of the time (n = 66), most of the time (n = 57) and all the
time (n = 73).
Table 2 Risk for the incidence of overweight/obesity and imp
category over the 6-year follow-up period
Rarely/Never Half of
(n = 97) (n = 66
Overweight/obesity
Age- and sex-adjusted OR (95% CI) 1.00 0.94 (0.
Multivariable-adjusted ORa (95% CI) 1.00 0.97 (0.
Impaired glucose tolerance/type 2 diabetes
Age- and sex-adjusted OR (95% CI) 1.00 0.91 (0.
Multivariable-adjusted ORa (95% CI) 1.00 0.96 (0.
aAdjusted for age, sex, smoking habits, total annual family income, daily caloric inta
body mass index ≥25 kg/m2. Impaired glucose tolerance/type 2 diabetes was defin
Organization criteria [26,27]. Abbreviations: OR odds ratio, CI confidence interval.
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versely associated with mortality risk [19]. Although
standing appears to be a better choice than sitting for
cardio-metabolic health, results of the present study sug-
gest that other important factors should be considered
(e.g. annual income and cardiorespiratory fitness) to ul-
timately prevent the development of chronic diseases.
The definition of standing time in the present study
(i.e. time spent standing at work or during the main oc-
cupation) suggests that participants are probably not
only standing still; light-intensity physical activity may
also be involved in this amount of time spent standing.
There is a growing body of evidence to suggest that
light-intensity physical activity (e.g. walking) confers
health benefits [16,34,35]. Although light-intensity phys-
ical activity is not typically part of physical activity
guidelines, important health benefits can certainly be
obtained at the lower end of the energy expenditure
continuum [8].
There are a number of biological mechanisms through
which greater time spent standing may lead to a reduced
risk of chronic diseases. Standing may have a measurable
impact on important metabolic processes, especially
those related to glycemic control and lipoprotein metab-
olism. In comparison to a day of prolonged sitting,
Latouche et al. showed that a day which incorporates
light intensity activity breaks results in increased expres-
sion of genes related to lipid and carbohydrate metabol-
ism in skeletal muscle [36]. Similarly, Hamilton et al.
reported that standing results in large increases in lipo-
protein lipase activity when compared to prolonged sed-
entary behavior in animal models [37]. In addition to
any direct metabolic impact, standing may also be asso-
ciated with reduced weight gain by slightly but consist-
ently increasing energy expenditure, as suggested by the
results of Buckley et al. [20].
There are several strengths and limitations of this
study that warrant discussion. Strengths of this study in-
clude its longitudinal design and the adjustment foraired glucose tolerance/type 2 diabetes by standing time
the time Most of the time All the time P for trend
) (n = 57) (n = 73)
53-1.48) 0.79 (0.34-1.44) 0.63 (0.21-1.22) <0.05
55-1.51) 0.88 (0.42-1.57) 0.85 (0.31-1.37) 0.19
47-1.49) 0.80 (0.31-1.53) 0.66 (0.22-1.27) <0.05
51-1.53) 0.90 (0.40-1.65) 0.91 (0.35-1.49) 0.36
ke, and submaximal working capacity. Overweight/obesity was defined as a
ed according to the American Diabetes Association and the World Health
Figure 2 Development of overweight/obesity (A) and impaired
glucose tolerance/type 2 diabetes (IGT/T2D) (B) according to
changes in standing time over the 6-year follow-up period
in adults. Data are presented as percentage. Overweight/obesity
was defined as a body mass index ≥25 kg/m2. Impaired glucose
tolerance/type 2 diabetes was defined according to the American
Diabetes Association and the World Health Organization criteria
[26,27]. Statistical significance was assessed by a chi-squared test
(P < 0.05 for all analyses). Change in standing time categories:
decreased (n = 82), maintained (n = 149) and increased (n = 62).
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between standing time and the incidence of chronic dis-
eases (e.g. caloric intake, cardiorespiratory fitness and so-
cioeconomic status). Furthermore, data were obtained
from both men and women and we used an approach
that should minimize confounding with repeated mea-
sures (baseline and year 6). However, our results need to
be interpreted in light of the following limitations. First,
the relatively small sample size limits statistical power
and more high quality and well powered studies are
needed to better appreciate the influence of standing
time on the development of chronic diseases. The
present study should thus be seen as an exploratory
analysis which needs to be replicated in larger cohorts.
Second, the exposure variable (standing time) was self-
reported from a questionnaire and its validity is uncertain.
Our findings are also limited to occupational standing, asopposed to total standing time. Third, the level of move-
ment/activity while standing was not known and some
people may have been more active than others during
this period. Fourth, the external generalizability of our
findings may be restricted to adults of Western European
descent. Finally, the possibility of residual confounding
by unmeasured variables is always a possibility in obser-
vational studies.
Conclusions
In summary, the present study is the first to examine
the association between occupational standing time
and the incidence of OW/OB and IGT/T2D in adults.
Our results suggest that standing time alone is not suf-
ficient to prevent the incidence of OW/OB and IGT/
T2D, which has implication for the risk of other chronic
diseases. Replication studies with longer follow-up pe-
riods and larger sample sizes are needed to better
understand the potential benefits of higher amounts of
standing time throughout the day on the prevention of
chronic diseases.
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